Pingping Shen

Nanjing University - Drum Tower Hospital

321 Zhong Shan Road

Nanjing, Jiangning District 210008

China

SCHOLARLY PAPERS

3

DOWNLOADS

25

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (3)

1.

CD133-Directed CAR T Cells in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Trial

Number of pages: 57 Posted: 18 Jan 2020
Government of the People's Republic of China - Department of Molecular Biology and Immunology, Government of the People's Republic of China - Department of Molecular Biology and Immunology, Nanjing University, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Department of Molecular Biology and Immunology, Government of the People's Republic of China - Department of Molecular Biology and Immunology, Government of the People's Republic of China - Department of Molecular Biology and Immunology, Nanjing University - Drum Tower Hospital and Government of the People's Republic of China - Department of Molecular Biology and Immunology
Downloads 13 (609,296)

Abstract:

Loading...

hepatocellular carcinoma, chimeric antigen receptor, CD133, biomarker

2.

Treatment of Obesity-Related Inflammation with a Novel Synthetic Pentacyclic Oleanane Triterpenoids via Modulation of Macrophages Polarization

EBioMedicine, Volume 45, July 2019, Pages 473-486, https://doi.org/10.1016/j.ebiom.2019.06.053
Number of pages: 42 Posted: 17 Mar 2019
Nanjing University, Nanjing University, Nanjing University, Nanjing University, Nanjing University, Nanjing University - Department of General Surgery, Nanjing University, Peking University, China Pharmaceutical University and Nanjing University - Drum Tower Hospital
Downloads 8 (643,979)

Abstract:

Loading...

inflammation; macrophage polarization; SO1989; fatty acid oxidation; adverse effects

3.

Efficacy, Safety and Biomarker Analysis of CD133-Directed CAR T Cells in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Trial

Number of pages: 19 Posted: 05 Feb 2020
Government of the People's Republic of China - Department of Molecular Biology and Immunology, Government of the People's Republic of China - Department of Molecular Biology and Immunology, Brandeis University - Department of Chemistry, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Department of Molecular Biology and Immunology, Government of the People's Republic of China - Department of Molecular Biology and Immunology, Government of the People's Republic of China - Department of Molecular Biology and Immunology, Nanjing University - Drum Tower Hospital and Government of the People's Republic of China - Department of Molecular Biology and Immunology
Downloads 4 (672,840)

Abstract:

Loading...

hepatocellular carcinoma, chimeric antigen receptor, CD133, biomarker